who-owns-walgreens

Who Owns Walgreens?

Walgreens is owned by the Walgreens Boots Alliance, which also owns Boots. The main shareholder of Walgreens Boots Alliance is Italian businessman Stefano Pessina, Executive Chairman of the Walgreens Boots Alliance Board, and his wife, Ornella Barra. Top institutional investors comprise The Vanguard Group (6.9%), BlackRock (6.4%), and State Street Corporation (5.5%).

Key Highlights

  • Ownership and Subsidiaries: Walgreens is a subsidiary of the Walgreens Boots Alliance, a global pharmaceuticals and retail company. The Walgreens Boots Alliance also owns Boots, a well-known pharmacy chain in the UK and other countries.
  • Stefano Pessina: Italian businessman Stefano Pessina is a central figure in the ownership of Walgreens Boots Alliance. He serves as the Executive Chairman of the Walgreens Boots Alliance Board. Pessina has played a significant role in shaping the company’s direction and strategy.
  • Ornella Barra: Ornella Barra, wife of Stefano Pessina, is another key figure in the ownership of Walgreens Boots Alliance. She has been actively involved in the pharmaceutical and retail industry and holds executive positions within the company.
  • Ownership Structure: Stefano Pessina and Ornella Barra, through their positions and ownership stakes, exert a considerable influence on the company’s decisions and direction.
  • Top Institutional Investors:
    • The Vanguard Group: The Vanguard Group is one of the largest investment management companies globally. It holds a significant stake in Walgreens Boots Alliance, with a ownership percentage of 6.9%.
    • BlackRock: BlackRock is another major investment management firm that holds a substantial stake in the company. Its ownership percentage is approximately 6.4%.
    • State Street Corporation: State Street Corporation, a leading financial services and investment company, is also a top institutional investor in Walgreens Boots Alliance, with an ownership percentage of about 5.5%.
  • Influence and Control: The presence of these institutional investors underscores the significance of Walgreens Boots Alliance in the investment landscape. The ownership and stake of these institutions contribute to the company’s financial stability and strategic decision-making.
  • Global Impact: Walgreens Boots Alliance’s ownership and shareholder composition highlight the company’s international reach and its role in the pharmaceutical and retail sectors on a global scale.

Related Visual Stories

Walgreens Boots Alliance Revenue

walgreens-boots-alliance-revenue
Walgreens Boots Alliance generated $268.19 billion in revenue in 2022, compared to $232.72 billion in 2021, and $208.62 billion in 2020.

Walgreens Boots Alliance Profits

walgreens-boots-profits
Walgreens Boots Alliance generated $1.99 billion in profits in 2022, compared to a net loss of $3.47 billion in 2021 and $1.62 billion in 2020.

Walgreens Revenue

walgreens-revenue-breakdown
Walgreens generated 74% of its revenue from Pharmacy, compared to 26% from Retail in 2022, 76% of revenue from Pharmacy, and 24% from Retail in 2021.

Walgreens Distribution Strategy

walgreens-distribution-strategy
Walgreen’s distribution strategy is skewed toward pharmacy, which in 2022 generated 74% of its revenue, compared to retail which generated 26% of its revenue.

Boots Revenue

boots-revenue-breakdown
Boots generated 51% of its revenues from wholesale, compared to 42% from retail and 17% from the pharmacy segment in 2022.

Boots Distribution Strategy

boots-distribution-strategy
Boots’ distribution strategy is skewed toward wholesale, which generated 51% of the company’s revenue in 2022, compared to 32% from retail and 17% from the pharmacy segment.

Related Visual Stories

CVS Revenue

cvs-revenue
CVS generated over $322 billion in revenue in 2022, compared to over $292 billion in 2021 and over $268 billion in 2020. In 2022, of CVS’s revenue, most of it came from products, followed by premiums and services.

CVS Profits

cvs-profits
CVS generated $4.15 billion in profits in 2022, compared to $7.91 billion in 2021 and $7.18 billion in 2020.

CVS Revenue Breakdown

cvs-revenue-breakdown

CVS Distribution Strategy

cvs-distribution-strategy
CVS’s distribution strategy is toward pharmacy, which in 2022 generated nearly 77% of the company’s revenue compared to front store & others, which generated over 23% of its revenue.

CVS Revenue By Channel

cvs-revenue-by-channel
In 2022, CVS generated most of its revenue from pharmacy (76.9%), compared to 76% of revenue from pharmacy in 2021 and 76.9% in 2020. The rest is generated by retail & others.

About The Author

Scroll to Top
FourWeekMBA